Literature DB >> 21510232

Prevalence of peripheral neuropathy in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Morteza Saeidi1, Payam Sasannejad, Mohsen Foroughipour, SaeedReza Shahami, Ali Shoeibi.   

Abstract

UNLABELLED: While the most common neurological disorder associated with Human T lymphotropic virus type-1 (HTLV-1) infection in the endemic areas is HTLV-1 associated myelopathy also know as tropical spastic paraparesis (HAM/TSP), other disorders such as optic neuropathy, peripheral neuropathy and cerebellar diseases have also been reported in patient with this infection. In this paper, we studied the prevalence of peripheral nerve involvement in patients with HAM/TSP.
METHODS: Seventy three patients diagnosed with HAM/TSP in accordance to criteria set by the World Health Organization (WHO) were evaluated in this cross-sectional study. Clinical and electrodiagnostic criteria were used for the diagnosis of peripheral neuropathy.
RESULTS: Electrodiagnostic studies showed that 30.1% of patients with HAM/TSP had peripheral nerve involvement. All patients had predominantly axonal neuropathy with sensory-motor polyneuropathy being the most common neuropathy observed in our patients. DISCUSSION AND
CONCLUSION: Peripheral neuropathy may be more common than previously thought and should be checked systematically in all patients with HAM/TSP.

Entities:  

Mesh:

Year:  2011        PMID: 21510232

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  2 in total

1.  Telomere Length, Proviral Load and Neurologic Impairment in HTLV-1 and HTLV-2-Infected Subjects.

Authors:  Benjamin Usadi; Roberta Bruhn; Jue Lin; Tzong-Hae Lee; Elizabeth Blackburn; Edward L Murphy
Journal:  Viruses       Date:  2016-08-11       Impact factor: 5.048

2.  Factors associated with pain in individuals infected by human T-cell lymphotropic virus type 1 (HTLV-1).

Authors:  Dislene N Dos Santos; Kionna O B Santos; Alaí B Paixão; Rosana Cristina P de Andrade; Davi T Costa; Daniel L S-Martin; Katia N Sá; Abrahão F Baptista
Journal:  Braz J Infect Dis       Date:  2016-12-21       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.